ARTICLE | Clinical News
Rasilamlo regulatory update
May 2, 2011 7:00 AM UTC
The European Commission approved Rasilamlo aliskiren/amlodipine to treat hypertension in patients not controlled with Novartis' Tekturna aliskiren or amlodipine alone. Rasilamlo is a single-pill comb...